New DHSC medicine supply guidance shows why wholesalers need clear GDP escalation, documentation and communication processes.
Let’s route your enquiry to the right place.
Your information will only be used by us in line with our Privacy Notice.
Let’s route your enquiry to the right place.
Your information will only be used by us in line with our Privacy Notice.
New DHSC medicine supply guidance shows why wholesalers need clear GDP escalation, documentation and communication processes.
An MHRA illegal medicines case shows why storage, packaging, distribution routes, GDP controls and WDA(H) readiness matter.
A recent MHRA recall shows why medicines wholesalers need strong storage, transport, quarantine and GDP quality controls.
An MHRA fake Mounjaro warning shows why wholesalers need strong product verification, supplier checks and GDP quality oversight.
A new MHRA safety update shows why medicine wholesalers need strong product information controls, GDP quality systems and RP oversight.
A latest MHRA defect notice shows why wholesalers need strong product information controls, documentation review and RP oversight.
An MHRA barcode defect notice shows why medicines wholesalers need strong stock identification, GDP controls and RP oversight.
An MHRA Braille packaging defect notice shows why medicines wholesalers need strong product information, documentation and RP oversight.
UK medicines supply disruption and ongoing MHRA oversight highlight why businesses need continuous GDP compliance support and operational review.
© 2026 TPMG Group Ltd. All rights reserved. TPMG Group Ltd is the commercial and operating hub within the wider TPMG Group. Company number: 14618789. Registered office: Cardinal Point, Park Road, Rickmansworth, WD3 1RE.